首页 > 最新文献

DNA Repair最新文献

英文 中文
Overexpression of the NEK8 kinase inhibits homologous recombination NEK8激酶过表达抑制同源重组
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-10-08 DOI: 10.1016/j.dnarep.2025.103902
Joshua L. Turner, Georgia Moore, Tyler J. McCraw, Jennifer M. Mason
Homologous recombination proteins maintain genome stability by repairing double strand breaks and protecting replication fork stability. Defects in homologous recombination results in cancer predisposition but can be exploited due to increased sensitivity to certain chemotherapeutics such as PARP inhibitors. The NEK8 kinase has roles in the replication response and homologous recombination. NEK8 is overexpressed in breast cancer, but the impact of NEK8 overexpression on homologous recombination has not been determined. Here, we demonstrate NEK8 overexpression inhibits RAD51 focus formation resulting in a defect in homologous recombination and degradation of stalled replication forks. Importantly, NEK8 overexpression sensitizes cells to the PARP inhibitor, Olaparib. Together, our results suggest NEK8 overexpressing tumors may be recombination-deficient and respond to chemotherapeutics that target defects in recombination such as Olaparib.
同源重组蛋白通过修复双链断裂和保护复制叉的稳定性来维持基因组的稳定性。同源重组的缺陷导致癌症易感性,但由于对某些化疗药物(如PARP抑制剂)的敏感性增加,可以利用。NEK8激酶在复制反应和同源重组中起作用。NEK8在乳腺癌中过表达,但NEK8过表达对同源重组的影响尚未确定。在这里,我们证明NEK8过表达抑制RAD51焦点形成,导致同源重组缺陷和停滞复制分叉的降解。重要的是,NEK8过表达使细胞对PARP抑制剂Olaparib敏感。总之,我们的研究结果表明NEK8过表达的肿瘤可能是重组缺陷的,并且对靶向重组缺陷的化疗药物(如奥拉帕尼)有反应。
{"title":"Overexpression of the NEK8 kinase inhibits homologous recombination","authors":"Joshua L. Turner,&nbsp;Georgia Moore,&nbsp;Tyler J. McCraw,&nbsp;Jennifer M. Mason","doi":"10.1016/j.dnarep.2025.103902","DOIUrl":"10.1016/j.dnarep.2025.103902","url":null,"abstract":"<div><div>Homologous recombination proteins maintain genome stability by repairing double strand breaks and protecting replication fork stability. Defects in homologous recombination results in cancer predisposition but can be exploited due to increased sensitivity to certain chemotherapeutics such as PARP inhibitors. The NEK8 kinase has roles in the replication response and homologous recombination. NEK8 is overexpressed in breast cancer, but the impact of NEK8 overexpression on homologous recombination has not been determined. Here, we demonstrate NEK8 overexpression inhibits RAD51 focus formation resulting in a defect in homologous recombination and degradation of stalled replication forks. Importantly, NEK8 overexpression sensitizes cells to the PARP inhibitor, Olaparib. Together, our results suggest NEK8 overexpressing tumors may be recombination-deficient and respond to chemotherapeutics that target defects in recombination such as Olaparib.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"155 ","pages":"Article 103902"},"PeriodicalIF":2.7,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145289859","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CPD photolyase evolution supports amphibian UV-sensitivity hypothesis CPD光解酶的进化支持两栖动物对紫外线敏感假说。
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-10-01 DOI: 10.1016/j.dnarep.2025.103900
James Eduardo Lago Londero , Rayana dos Santos Feltrin , Ana Lucia Anversa Segatto , André Passaglia Schuch
The UV-sensitivity hypothesis for amphibian decline proposes that interspecific variation in cyclobutane pyrimidine dimer (CPD) photolyase activity determines species’ UV sensitivity, which is linked to their natural history and population trends. Here, to shed light on the molecular basis of UV resistance variation, we investigated the evolutionary dynamics of CPD photolyases in amphibians focusing on regions and sites relevant to protein function. Our evolutionary analyses revealed that amino acids critical for CPD photolyase function are highly conserved and their codons have been evolving under purifying selection. Three tryptophan residues, critical for light-dependent repair and potentially for dark repair, are highly conserved in CPD photolyases across species. Nevertheless, we identified variations in functionally relevant CPD photolyase amino acids across amphibian clades, some of which are predicted to contract the active site and destabilize the protein structure. Caudata CPD photolyases contain functionally relevant variations likely linked to the high UV sensitivity of salamanders and newts. In Gymnophiona, we found relaxed purifying selection in CPD photolyase codons, as well as functionally relevant amino acid variations, likely reflecting the fossorial, dark-dwelling lifestyle of caecilians. Strikingly, most amphibian species with decreasing populations exhibit CPD photolyases with functionally relevant amino acid variations, and this pattern is even stronger for variations that disrupt protein structure. For example, two structurally disruptive, functionally relevant amino acid variations co-occur in CPD photolyases of species from the genera Bombina (Anura) and Ambystoma (Caudata), most of which exhibit declining populations. This study shows that species-specific differences in CPD photolyases underscore the UV-sensitivity hypothesis in amphibian ecology and conservation.
两栖动物衰退的紫外线敏感性假说认为,环丁烷嘧啶二聚体(CPD)光解酶活性的种间差异决定了物种的紫外线敏感性,这与它们的自然历史和种群趋势有关。为了揭示抗紫外线变异的分子基础,我们研究了两栖动物CPD光解酶的进化动力学,重点研究了与蛋白质功能相关的区域和位点。我们的进化分析表明,对CPD光解酶功能至关重要的氨基酸是高度保守的,它们的密码子是在纯化选择下进化的。三种色氨酸残基对光依赖性修复和潜在的暗修复至关重要,它们在CPD光分解酶中高度保守。然而,我们在两栖动物分支中发现了功能相关的CPD光解酶氨基酸的变化,其中一些被预测会收缩活性位点并破坏蛋白质结构的稳定。尾科CPD光解酶含有功能相关的变异,可能与蝾螈和蝾螈的高紫外线敏感性有关。在裸子螈(Gymnophiona)中,我们发现CPD光解酶密码子的纯化选择宽松,以及功能相关的氨基酸变异,可能反映了裸子螈的化石、黑暗生活方式。引人注目的是,大多数种群减少的两栖动物都表现出具有功能相关氨基酸变异的CPD光解酶,这种模式对于破坏蛋白质结构的变异更为强烈。例如,在bomina属(无尾目)和Ambystoma属(尾纲)的CPD光解酶中,两种结构上具有破坏性、功能上相关的氨基酸变异同时发生,其中大多数物种的种群数量呈下降趋势。该研究表明,CPD光解酶的物种特异性差异强调了两栖动物生态学和保护中的紫外线敏感性假说。
{"title":"CPD photolyase evolution supports amphibian UV-sensitivity hypothesis","authors":"James Eduardo Lago Londero ,&nbsp;Rayana dos Santos Feltrin ,&nbsp;Ana Lucia Anversa Segatto ,&nbsp;André Passaglia Schuch","doi":"10.1016/j.dnarep.2025.103900","DOIUrl":"10.1016/j.dnarep.2025.103900","url":null,"abstract":"<div><div>The UV-sensitivity hypothesis for amphibian decline proposes that interspecific variation in cyclobutane pyrimidine dimer (CPD) photolyase activity determines species’ UV sensitivity, which is linked to their natural history and population trends. Here, to shed light on the molecular basis of UV resistance variation, we investigated the evolutionary dynamics of CPD photolyases in amphibians focusing on regions and sites relevant to protein function. Our evolutionary analyses revealed that amino acids critical for CPD photolyase function are highly conserved and their codons have been evolving under purifying selection. Three tryptophan residues, critical for light-dependent repair and potentially for dark repair, are highly conserved in CPD photolyases across species. Nevertheless, we identified variations in functionally relevant CPD photolyase amino acids across amphibian clades, some of which are predicted to contract the active site and destabilize the protein structure. Caudata CPD photolyases contain functionally relevant variations likely linked to the high UV sensitivity of salamanders and newts. In Gymnophiona, we found relaxed purifying selection in CPD photolyase codons, as well as functionally relevant amino acid variations, likely reflecting the fossorial, dark-dwelling lifestyle of caecilians. Strikingly, most amphibian species with decreasing populations exhibit CPD photolyases with functionally relevant amino acid variations, and this pattern is even stronger for variations that disrupt protein structure. For example, two structurally disruptive, functionally relevant amino acid variations co-occur in CPD photolyases of species from the genera <em>Bombina</em> (Anura) and <em>Ambystoma</em> (Caudata), most of which exhibit declining populations. This study shows that species-specific differences in CPD photolyases underscore the UV-sensitivity hypothesis in amphibian ecology and conservation.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"154 ","pages":"Article 103900"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145246107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The comet assay: A contemporary approach for detecting genomic instability 彗星试验:一种检测基因组不稳定性的当代方法。
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-10-01 DOI: 10.1016/j.dnarep.2025.103899
Xingkai He , Feng Chen , Linmin Zhou , Yuanqing Sun , Qi Liu , Weicheng Chen , Luyao Zhu , Jun Zhang , Wei-Guo Zhu
The comet assay has evolved into a high-resolution, multifunctional technique for evaluating DNA damage, repair capacity, and epigenetic modifications. Over the past fifteen years, significant advancements-including the enzyme-modified comet assays (EMCA), Comet-FISH, and high-throughput platforms have substantially expanded its analytical capabilities. Specialized formats like the Flash comet assay and the BrdU comet assay further enhance the discrimination of DNA strand break types and replication-associated damage. Despite these innovations, issues related to standardization, reproducibility, and inter-laboratory consistency remain. Initiatives such as the Minimum Information for Reporting Comet Assay (MIRCA) guidelines, alongside the integration of automated imaging and machine learning, are being implemented to address these challenges. With its growing applications in environmental toxicology, biomonitoring, and clinical research, the comet assay is increasingly recognized as a key tool in precision toxicology and personalized medicine. This review highlights major technical developments and emerging applications of the comet assay over the past fifteen years, discusses sources of experimental variability and strategies for optimization, and provides an update on current laboratory protocols for assessing DNA damage induced by genotoxic agents.
彗星分析已经发展成为一种高分辨率、多功能的技术,用于评估DNA损伤、修复能力和表观遗传修饰。在过去的15年里,包括酶修饰彗星测定法(EMCA)、comet - fish和高通量平台在内的重大进步大大扩展了其分析能力。Flash彗星分析和BrdU彗星分析等专门格式进一步增强了DNA链断裂类型和复制相关损伤的区分。尽管有这些创新,与标准化、可重复性和实验室间一致性相关的问题仍然存在。为了应对这些挑战,正在实施诸如报告彗星分析(MIRCA)指南的最低信息(Minimum Information for Reporting Comet Assay)以及自动化成像和机器学习的集成等举措。随着彗星分析在环境毒理学、生物监测和临床研究中的应用越来越广泛,彗星分析越来越被认为是精确毒理学和个性化医疗的关键工具。本综述重点介绍了过去15年来彗星分析的主要技术发展和新兴应用,讨论了实验变异性的来源和优化策略,并提供了评估遗传毒性物质诱导的DNA损伤的当前实验室方案的更新。
{"title":"The comet assay: A contemporary approach for detecting genomic instability","authors":"Xingkai He ,&nbsp;Feng Chen ,&nbsp;Linmin Zhou ,&nbsp;Yuanqing Sun ,&nbsp;Qi Liu ,&nbsp;Weicheng Chen ,&nbsp;Luyao Zhu ,&nbsp;Jun Zhang ,&nbsp;Wei-Guo Zhu","doi":"10.1016/j.dnarep.2025.103899","DOIUrl":"10.1016/j.dnarep.2025.103899","url":null,"abstract":"<div><div>The comet assay has evolved into a high-resolution, multifunctional technique for evaluating DNA damage, repair capacity, and epigenetic modifications. Over the past fifteen years, significant advancements-including the enzyme-modified comet assays (EMCA), Comet-FISH, and high-throughput platforms have substantially expanded its analytical capabilities. Specialized formats like the Flash comet assay and the BrdU comet assay further enhance the discrimination of DNA strand break types and replication-associated damage. Despite these innovations, issues related to standardization, reproducibility, and inter-laboratory consistency remain. Initiatives such as the Minimum Information for Reporting Comet Assay (MIRCA) guidelines, alongside the integration of automated imaging and machine learning, are being implemented to address these challenges. With its growing applications in environmental toxicology, biomonitoring, and clinical research, the comet assay is increasingly recognized as a key tool in precision toxicology and personalized medicine. This review highlights major technical developments and emerging applications of the comet assay over the past fifteen years, discusses sources of experimental variability and strategies for optimization, and provides an update on current laboratory protocols for assessing DNA damage induced by genotoxic agents.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"154 ","pages":"Article 103899"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145214977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PARP enzyme synthesis of protein-free poly(ADP-ribose): Implications for DNA damage signaling and repair 无蛋白聚核糖(adp -核糖)的PARP酶合成:对DNA损伤信号传导和修复的意义
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-10-01 DOI: 10.1016/j.dnarep.2025.103898
Marie-France Langelier, John M. Pascal
Poly(ADP-ribose) or PAR is a versatile signaling molecule with a broad impact on human biology. PAR is a prominent indicator of cellular DNA damage and genomic transactions such as replication and transcription. Canonically, human PARP enzymes create PAR as a modification on proteins. Recently, PARP enzymes were found to create free PAR molecules that are not attached to protein. Free PAR has been implicated in cell death signaling, but the production of free PAR was assumed to be generated by glycohydrolases breaking down protein-linked PAR into smaller fragments. The direct de novo production of free PAR by PARP1 occurs alongside the synthesis of protein-linked PAR in response to DNA damage, suggesting a more prevalent role for free PAR in DNA damage signaling. This review outlines the discovery of free PAR synthesis in biochemical reactions and in cellular models of the DNA damage response. The implications for this finding are summarized in the context of DNA damage signaling and associated processes of biomolecular condensate formation and Parthanatos cell death signaling.
聚(adp -核糖)或PAR是一种多功能信号分子,对人类生物学有着广泛的影响。PAR是细胞DNA损伤和基因组交易(如复制和转录)的重要指标。通常,人类的PARP酶会在蛋白质上产生PARP修饰物。最近,人们发现PARP酶可以产生不附着在蛋白质上的自由PAR分子。游离PAR与细胞死亡信号有关,但游离PAR的产生被认为是通过糖水解酶将蛋白质连接的PAR分解成更小的片段而产生的。在DNA损伤反应中,PARP1直接从头产生游离PAR,同时合成蛋白连接的PAR,这表明游离PAR在DNA损伤信号传导中起着更普遍的作用。本文综述了在生物化学反应和DNA损伤反应的细胞模型中游离PAR合成的发现。这一发现的意义在DNA损伤信号和生物分子凝聚形成的相关过程以及Parthanatos细胞死亡信号的背景下进行了总结。
{"title":"PARP enzyme synthesis of protein-free poly(ADP-ribose): Implications for DNA damage signaling and repair","authors":"Marie-France Langelier,&nbsp;John M. Pascal","doi":"10.1016/j.dnarep.2025.103898","DOIUrl":"10.1016/j.dnarep.2025.103898","url":null,"abstract":"<div><div>Poly(ADP-ribose) or PAR is a versatile signaling molecule with a broad impact on human biology. PAR is a prominent indicator of cellular DNA damage and genomic transactions such as replication and transcription. Canonically, human PARP enzymes create PAR as a modification on proteins. Recently, PARP enzymes were found to create free PAR molecules that are not attached to protein. Free PAR has been implicated in cell death signaling, but the production of free PAR was assumed to be generated by glycohydrolases breaking down protein-linked PAR into smaller fragments. The direct de novo production of free PAR by PARP1 occurs alongside the synthesis of protein-linked PAR in response to DNA damage, suggesting a more prevalent role for free PAR in DNA damage signaling. This review outlines the discovery of free PAR synthesis in biochemical reactions and in cellular models of the DNA damage response. The implications for this finding are summarized in the context of DNA damage signaling and associated processes of biomolecular condensate formation and Parthanatos cell death signaling.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"154 ","pages":"Article 103898"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145217764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UBE2C promotes cell cycle progression and suppresses DNA damage-induced apoptosis in triple-negative breast cancer UBE2C促进三阴性乳腺癌细胞周期进程,抑制DNA损伤诱导的细胞凋亡。
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-10-01 DOI: 10.1016/j.dnarep.2025.103901
Qin Hu , Kewu Wang , Chuanrong Chen , Jian Ding , Yang He , Zhaoning Ji

Background

Triple-negative breast cancer (TNBC), characterized by its aggressiveness, constitutes a unique breast cancer subtype, lacking effective targeted therapies. Its progression is often driven by cell cycle control dysfunction, impaired DNA damage handling, and resistance to apoptosis. Ubiquitin-conjugating enzyme E2C (UBE2C), an essential mitotic regulator, has been implicated in tumorigenesis and therapy resistance in several tumor types, but its relevance in TNBC is still poorly understood. This study focused on investigating the expression and functional importance of UBE2C in TNBC development.

Methods

UBE2C levels and their clinical relevance in TNBC were evaluated via transcriptomic data from TCGA and GTEx. Gene set enrichment analysis (GSEA) was performed to pinpoint UBE2C-associated biological pathways. Functional validation was conducted in MDA-MB-231 TNBC cell lines via qRT-PCR, Western blotting, flow cytometry, comet assay, and TUNEL staining to examine the effects of UBE2C modulation on cell cycle dynamics, DNA damage response, and apoptosis.

Results

UBE2C exhibited marked overexpression in TNBC tissues and cell lines relative to normal controls (P < 0.01), and its high expression was correlated with reduced overall survival (P = 0.01). GSEA indicated enrichment of cell cycle and DNA repair pathways in UBE2C-high samples, while apoptosis pathways were suppressed (FDR < 0.25). Functional assays demonstrated that UBE2C overexpression accelerated G1/S and G2/M transitions (P < 0.01), reduced DNA damage accumulation (P < 0.01), and suppressed apoptotic processes (P < 0.01), while UBE2C knockdown elicited the opposite effects.

Conclusion

UBE2C promotes TNBC cell survival through modulation of cell cycle progression, DNA repair mechanisms, and apoptosis signaling. These results suggested that UBE2C could be considered a promising biomarker and therapeutic target, particularly in combination with DNA-damaging agents for personalized TNBC therapy.
背景:三阴性乳腺癌(TNBC)具有侵袭性,是一种独特的乳腺癌亚型,缺乏有效的靶向治疗。其进展通常由细胞周期控制功能障碍、DNA损伤处理受损和细胞凋亡抵抗驱动。泛素偶联酶E2C (UBE2C)是一种重要的有丝分裂调节剂,与几种肿瘤类型的肿瘤发生和治疗耐药有关,但其在TNBC中的相关性仍然知之甚少。本研究的重点是探讨UBE2C在TNBC发展中的表达及其功能重要性。方法:通过TCGA和GTEx的转录组学数据评估TNBC中UBE2C水平及其临床相关性。通过基因集富集分析(GSEA)确定ube2c相关的生物学途径。通过qRT-PCR、Western blotting、流式细胞术、comet实验和TUNEL染色对MDA-MB-231 TNBC细胞株进行功能验证,研究UBE2C调控对细胞周期动力学、DNA损伤反应和凋亡的影响。结果:与正常对照相比,UBE2C在TNBC组织和细胞系中表现出明显的过表达(P 结论:UBE2C通过调节细胞周期进程、DNA修复机制和凋亡信号传导促进TNBC细胞存活。这些结果表明,UBE2C可以被认为是一个有前景的生物标志物和治疗靶点,特别是与dna损伤药物联合用于个性化TNBC治疗。
{"title":"UBE2C promotes cell cycle progression and suppresses DNA damage-induced apoptosis in triple-negative breast cancer","authors":"Qin Hu ,&nbsp;Kewu Wang ,&nbsp;Chuanrong Chen ,&nbsp;Jian Ding ,&nbsp;Yang He ,&nbsp;Zhaoning Ji","doi":"10.1016/j.dnarep.2025.103901","DOIUrl":"10.1016/j.dnarep.2025.103901","url":null,"abstract":"<div><h3>Background</h3><div>Triple-negative breast cancer (TNBC), characterized by its aggressiveness, constitutes a unique breast cancer subtype, lacking effective targeted therapies. Its progression is often driven by cell cycle control dysfunction, impaired DNA damage handling, and resistance to apoptosis. Ubiquitin-conjugating enzyme E2C (UBE2C), an essential mitotic regulator, has been implicated in tumorigenesis and therapy resistance in several tumor types, but its relevance in TNBC is still poorly understood. This study focused on investigating the expression and functional importance of UBE2C in TNBC development.</div></div><div><h3>Methods</h3><div>UBE2C levels and their clinical relevance in TNBC were evaluated via transcriptomic data from TCGA and GTEx. Gene set enrichment analysis (GSEA) was performed to pinpoint UBE2C-associated biological pathways. Functional validation was conducted in MDA-MB-231 TNBC cell lines via qRT-PCR, Western blotting, flow cytometry, comet assay, and TUNEL staining to examine the effects of UBE2C modulation on cell cycle dynamics, DNA damage response, and apoptosis.</div></div><div><h3>Results</h3><div>UBE2C exhibited marked overexpression in TNBC tissues and cell lines relative to normal controls (P &lt; 0.01), and its high expression was correlated with reduced overall survival (P = 0.01). GSEA indicated enrichment of cell cycle and DNA repair pathways in UBE2C-high samples, while apoptosis pathways were suppressed (FDR &lt; 0.25). Functional assays demonstrated that UBE2C overexpression accelerated G1/S and G2/M transitions (P &lt; 0.01), reduced DNA damage accumulation (P &lt; 0.01), and suppressed apoptotic processes (P &lt; 0.01), while UBE2C knockdown elicited the opposite effects.</div></div><div><h3>Conclusion</h3><div>UBE2C promotes TNBC cell survival through modulation of cell cycle progression, DNA repair mechanisms, and apoptosis signaling. These results suggested that UBE2C could be considered a promising biomarker and therapeutic target, particularly in combination with DNA-damaging agents for personalized TNBC therapy.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"154 ","pages":"Article 103901"},"PeriodicalIF":2.7,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145294840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanistic insights into RAD51-mediated nucleosome binding and remodeling in homologous recombination 同源重组中rad51介导的核小体结合和重塑的机制研究。
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-09-13 DOI: 10.1016/j.dnarep.2025.103891
Takuro Shioi , Suguru Hatazawa , Yoshimasa Takizawa , Hitoshi Kurumizaka
Eukaryotic cells organize their genomic DNA into chromatin to achieve both compact packaging and precise regulation of essential processes, including DNA repair. Depending on the type of damage, distinct repair pathways are activated through the targeted recruitment of repair factors to chromatin. RAD51 is the central recombinase in homologous recombination (HR) and forms nucleoprotein filaments, but its mode of chromatin engagement has remained elusive. In this review, we summarize recent progress in the structural and biochemical understanding of DNA repair within chromatin, with a particular focus on RAD51 and its role in HR. Specifically, we review newly determined cryo-electron microscopy (cryo-EM) structures of RAD51 bound to nucleosomes, revealing how RAD51 assembles on chromatin, recognizes DNA damage sites, and remodels nucleosomes into filamentous intermediates. We summarize current insights into how HR-associated proteins regulate RAD51 activity on chromatin, ensuring the fidelity of each step in HR. We conclude by outlining future directions for elucidating the downstream mechanisms of RAD51-mediated HR in the chromatin context.
真核细胞将其基因组DNA组织成染色质,以实现紧凑的包装和精确的基本过程调节,包括DNA修复。根据损伤的类型,不同的修复途径通过靶向募集修复因子到染色质而被激活。RAD51是同源重组(homologous recombination, HR)中的中心重组酶,可形成核蛋白细丝,但其与染色质结合的模式尚不清楚。在这篇综述中,我们总结了最近在染色质内DNA修复的结构和生化理解方面的进展,特别关注RAD51及其在HR中的作用。具体来说,我们回顾了最近确定的与核小体结合的RAD51的冷冻电镜(cro - em)结构,揭示了RAD51如何在染色质上组装,识别DNA损伤位点,并将核小体重塑为丝状中间体。我们总结了目前关于HR相关蛋白如何调节RAD51在染色质上的活性的见解,确保HR中每个步骤的保真度。最后,我们概述了未来在染色质背景下阐明rad51介导的HR下游机制的方向。
{"title":"Mechanistic insights into RAD51-mediated nucleosome binding and remodeling in homologous recombination","authors":"Takuro Shioi ,&nbsp;Suguru Hatazawa ,&nbsp;Yoshimasa Takizawa ,&nbsp;Hitoshi Kurumizaka","doi":"10.1016/j.dnarep.2025.103891","DOIUrl":"10.1016/j.dnarep.2025.103891","url":null,"abstract":"<div><div>Eukaryotic cells organize their genomic DNA into chromatin to achieve both compact packaging and precise regulation of essential processes, including DNA repair. Depending on the type of damage, distinct repair pathways are activated through the targeted recruitment of repair factors to chromatin. RAD51 is the central recombinase in homologous recombination (HR) and forms nucleoprotein filaments, but its mode of chromatin engagement has remained elusive. In this review, we summarize recent progress in the structural and biochemical understanding of DNA repair within chromatin, with a particular focus on RAD51 and its role in HR. Specifically, we review newly determined cryo-electron microscopy (cryo-EM) structures of RAD51 bound to nucleosomes, revealing how RAD51 assembles on chromatin, recognizes DNA damage sites, and remodels nucleosomes into filamentous intermediates. We summarize current insights into how HR-associated proteins regulate RAD51 activity on chromatin, ensuring the fidelity of each step in HR. We conclude by outlining future directions for elucidating the downstream mechanisms of RAD51-mediated HR in the chromatin context.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"154 ","pages":"Article 103891"},"PeriodicalIF":2.7,"publicationDate":"2025-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145088633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editors’ note Penny Jeggo and Bennett Van Houten 编者按潘妮·杰戈和班尼特·范·豪顿。
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-09-01 DOI: 10.1016/j.dnarep.2025.103862
Penny Jeggo, Bennett Van Houten
{"title":"Editors’ note Penny Jeggo and Bennett Van Houten","authors":"Penny Jeggo,&nbsp;Bennett Van Houten","doi":"10.1016/j.dnarep.2025.103862","DOIUrl":"10.1016/j.dnarep.2025.103862","url":null,"abstract":"","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"153 ","pages":"Article 103862"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144565567","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to “Unveiling cGAS mechanisms: Insights into DNA damage and immune sensing in cancer” [DNA Repair 152 (2025) 103868] “揭开cGAS机制:对癌症中DNA损伤和免疫感知的见解”[DNA修复152(2025)103868]的更正。
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-09-01 DOI: 10.1016/j.dnarep.2025.103878
Min-Guk Cho , Gaorav P. Gupta
{"title":"Corrigendum to “Unveiling cGAS mechanisms: Insights into DNA damage and immune sensing in cancer” [DNA Repair 152 (2025) 103868]","authors":"Min-Guk Cho ,&nbsp;Gaorav P. Gupta","doi":"10.1016/j.dnarep.2025.103878","DOIUrl":"10.1016/j.dnarep.2025.103878","url":null,"abstract":"","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"153 ","pages":"Article 103878"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144769462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The B cell dilemma: Diversity or fidelity? B细胞的困境:多样性还是保真性?
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-09-01 DOI: 10.1016/j.dnarep.2025.103888
Maria Berruezo-Llacuna , Eleni Kabrani , Michela Di Virgilio
The ability of B lymphocytes to diversify immunoglobulin (Ig) genes is central to the generation of high-affinity, class-switched antibodies and the establishment of effective humoral immunity. This diversification is achieved through three DNA remodeling processes that occur at defined stages of B cell development and maturation: V(D)J recombination, somatic hypermutation (SHM), and class switch recombination (CSR). These reactions all rely on the induction of programmed DNA lesions at Ig genes and their productive resolution by ubiquitous DNA repair pathways. However, such physiological sources of genotoxic stress render B cells vulnerable to genome instability, including mutations and chromosomal translocations that drive malignancies. Therefore, B cells have evolved complex regulatory networks that ensure efficient Ig gene diversification while minimizing the risk of unproductive or deleterious repair outcomes. In this review, we integrate foundational studies with recent mechanistic advances to outline how B cells exploit, coordinate, and constrain DNA repair to balance immune receptor diversification with the preservation of genome integrity.
B淋巴细胞使免疫球蛋白(Ig)基因多样化的能力对于产生高亲和力、类转换抗体和建立有效的体液免疫至关重要。这种多样化是通过发生在B细胞发育和成熟的特定阶段的三个DNA重塑过程实现的:V(D)J重组、体细胞超突变(SHM)和类开关重组(CSR)。这些反应都依赖于Ig基因的程序性DNA损伤的诱导,以及它们通过普遍存在的DNA修复途径的有效解决。然而,这种基因毒性应激的生理来源使B细胞易受基因组不稳定的影响,包括导致恶性肿瘤的突变和染色体易位。因此,B细胞进化出了复杂的调控网络,以确保高效的Ig基因多样化,同时最大限度地降低非生产性或有害修复结果的风险。在这篇综述中,我们整合了基础研究和最近的机制进展,概述了B细胞如何利用、协调和限制DNA修复来平衡免疫受体多样化和保持基因组完整性。
{"title":"The B cell dilemma: Diversity or fidelity?","authors":"Maria Berruezo-Llacuna ,&nbsp;Eleni Kabrani ,&nbsp;Michela Di Virgilio","doi":"10.1016/j.dnarep.2025.103888","DOIUrl":"10.1016/j.dnarep.2025.103888","url":null,"abstract":"<div><div>The ability of B lymphocytes to diversify immunoglobulin (<em>Ig</em>) genes is central to the generation of high-affinity, class-switched antibodies and the establishment of effective humoral immunity. This diversification is achieved through three DNA remodeling processes that occur at defined stages of B cell development and maturation: V(D)J recombination, somatic hypermutation (SHM), and class switch recombination (CSR). These reactions all rely on the induction of programmed DNA lesions at <em>Ig</em> genes and their productive resolution by ubiquitous DNA repair pathways. However, such physiological sources of genotoxic stress render B cells vulnerable to genome instability, including mutations and chromosomal translocations that drive malignancies. Therefore, B cells have evolved complex regulatory networks that ensure efficient <em>Ig</em> gene diversification while minimizing the risk of unproductive or deleterious repair outcomes. In this review, we integrate foundational studies with recent mechanistic advances to outline how B cells exploit, coordinate, and constrain DNA repair to balance immune receptor diversification with the preservation of genome integrity.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"153 ","pages":"Article 103888"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144989057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contributions of DNA double strand break repair pathways to DNA crosslink repair DNA双链断裂修复途径对DNA交联修复的贡献
IF 2.7 3区 生物学 Q2 GENETICS & HEREDITY Pub Date : 2025-09-01 DOI: 10.1016/j.dnarep.2025.103889
Gerarda van de Kamp , Israel Tojal da Silva , Sander Barnhoorn , Roland Kanaar , Jeroen Essers
DNA crosslink-inducing drugs are widely used in clinical settings for treatment of solid tumors. Double strand breaks (DSBs) that arise during interstrand crosslink (ICL) repair are crucial determinants of the therapeutic response, as they lead to cell death if not repaired. DSBs can be repaired through non-homologous end joining (NHEJ), theta-mediated end joining (TMEJ), and homologous recombination (HR). HR is considered a major pathway for repairing DSBs induced during ICL repair. In this study, we examine the roles of NHEJ, TMEJ, and HR in ICL repair using mouse embryonic stem (mES) cells. We show that DNA-PKcs-deficient mES cells are resistant to the crosslinkers mitomycin C (MMC), cisplatin and carboplatin, contrasting with the increased sensitivity observed in mES cells lacking Rad54. Furthermore, the absence of DNA-PKcs correlates with enhanced HR activity, as evidenced by an increased number of Rad54 foci following MMC treatment. The combined knock-outof DNA-PKcs and Rad54 reduces sensitivity to crosslinkers compared to cells lacking only Rad54, suggesting the involvement of another DSB repair pathway besides HR. We found that TMEJ deficiency can sensitize cells to cisplatin, particularly in those lacking NHEJ and HR repair. This suggests that TMEJ contributes to cell survival following cisplatin treatment. In clinical settings, higher PRKDC expression correlates with poorer survival, while elevated RAD54L and POLQ expression correlates with better survival in cisplatin-treated cervical and head and neck cancers. These findings reflect the opposing roles of NHEJ versus HR and TMEJ in replication-associated DSB repair, as observed in vitro.
DNA交联诱导药物广泛应用于实体肿瘤的临床治疗。在链间交联(ICL)修复过程中出现的双链断裂(DSBs)是治疗反应的关键决定因素,因为如果不进行修复,它们会导致细胞死亡。dsb可通过非同源末端连接(NHEJ)、θ介导末端连接(TMEJ)和同源重组(HR)修复。HR被认为是修复ICL修复过程中诱导的dsb的主要途径。在这项研究中,我们研究了NHEJ、TMEJ和HR在小鼠胚胎干细胞(mES) ICL修复中的作用。我们发现,dna - pkcs缺陷的mES细胞对交联剂丝裂霉素C (MMC)、顺铂和卡铂具有耐药性,而缺乏Rad54的mES细胞则具有更高的敏感性。此外,DNA-PKcs的缺失与HR活性的增强相关,正如MMC治疗后Rad54灶数量增加所证明的那样。与仅缺乏Rad54的细胞相比,DNA-PKcs和Rad54的联合敲除降低了对交联剂的敏感性,这表明除了HR之外还参与了另一种DSB修复途径。我们发现TMEJ缺乏可以使细胞对顺铂敏感,特别是那些缺乏NHEJ和HR修复的细胞。这表明TMEJ有助于顺铂治疗后的细胞存活。在临床环境中,在顺铂治疗的宫颈癌和头颈癌中,较高的PRKDC表达与较差的生存率相关,而升高的RAD54L和POLQ表达与较好的生存率相关。这些发现反映了在体外观察到的NHEJ与HR和TMEJ在复制相关的DSB修复中的相反作用。
{"title":"Contributions of DNA double strand break repair pathways to DNA crosslink repair","authors":"Gerarda van de Kamp ,&nbsp;Israel Tojal da Silva ,&nbsp;Sander Barnhoorn ,&nbsp;Roland Kanaar ,&nbsp;Jeroen Essers","doi":"10.1016/j.dnarep.2025.103889","DOIUrl":"10.1016/j.dnarep.2025.103889","url":null,"abstract":"<div><div>DNA crosslink-inducing drugs are widely used in clinical settings for treatment of solid tumors. Double strand breaks (DSBs) that arise during interstrand crosslink (ICL) repair are crucial determinants of the therapeutic response, as they lead to cell death if not repaired. DSBs can be repaired through non-homologous end joining (NHEJ), theta-mediated end joining (TMEJ), and homologous recombination (HR). HR is considered a major pathway for repairing DSBs induced during ICL repair. In this study, we examine the roles of NHEJ, TMEJ, and HR in ICL repair using mouse embryonic stem (mES) cells. We show that DNA-PK<sub>cs</sub>-deficient mES cells are resistant to the crosslinkers mitomycin C (MMC), cisplatin and carboplatin, contrasting with the increased sensitivity observed in mES cells lacking Rad54. Furthermore, the absence of DNA-PK<sub>cs</sub> correlates with enhanced HR activity, as evidenced by an increased number of Rad54 foci following MMC treatment. The combined knock-outof DNA-PK<sub>cs</sub> and Rad54 reduces sensitivity to crosslinkers compared to cells lacking only Rad54, suggesting the involvement of another DSB repair pathway besides HR. We found that TMEJ deficiency can sensitize cells to cisplatin, particularly in those lacking NHEJ and HR repair. This suggests that TMEJ contributes to cell survival following cisplatin treatment. In clinical settings, higher <em>PRKDC</em> expression correlates with poorer survival, while elevated <em>RAD54L</em> and <em>POLQ</em> expression correlates with better survival in cisplatin-treated cervical and head and neck cancers. These findings reflect the opposing roles of NHEJ versus HR and TMEJ in replication-associated DSB repair, as observed <em>in vitro</em>.</div></div>","PeriodicalId":300,"journal":{"name":"DNA Repair","volume":"153 ","pages":"Article 103889"},"PeriodicalIF":2.7,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145004361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
DNA Repair
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1